JH and YL supervised the study
We identified a lead candidate, azaA8 (Ala8aza-Ala in an Arg34-GLP-1 background), that resists DPP-4 degradation, retains low-picomolar receptor agonist potency, and produces significant metabolic benefits in both lean and diet-induced obese mice

What patients praise: Fast prescription approvals multiple reviewers report same-day or 48-hour turnaround Effective weight loss results on injectable formats, with losses of 12 lbs in 6 weeks and similar results cited Responsive provider messaging for clinical questions Successful insurance coordination multiple reviewers describe Zealthy successfully navigating prior authorizations and getting brand-name GLP-1s covered at roughly $25/month Affordable compounded pricing relative to brand-name retail costs Common complaints: Recurring charges after cancellation described by a substantial volume of reviewers as ongoing for months or years, with multiple reviewers filing credit card disputes and BBB complaints Billing under alternate merchant names (ZFit, GLP1, FitRX) after cancellation, making disputes more difficult to identify and file Charges taken before prescription approval some reviewers report paying before clinical review and not receiving medication or refunds Long shipping times and medication not arriving some reviewers report waiting more than three weeks from sign-up to first order Customer service described as difficult to reach, with email as the primary channel and phone support inconsistently available Compounding Pharmacies Used Zealthy-sourced compounded drugs are prepared by a state-licensed sterile compounding pharmacy, but the specific pharmacy or pharmacies are not publicly named on the website

CYP2E1 potentiates binge alcohol-induced gut leakiness, steatohepatitis, and apoptosis